Overview


The expression vector is a virus or plasmid that's specifically designed to express genes in cells. This vector is widely used to produce protein. These vectors have the basic characteristics of a vector, such as ori (origin and replication), insertion site, a selectable mark, etc. They also contain regulatory elements that aid protein synthesis. The vector DNA fragment contains a sequence that is suitable for protein synthesis. An expression vector is a sequence upstream from the cloned genes that control transcription and translation. The lacUV promoter is a strong but inducible expression vector. The artificial inducer IPTG is used to stimulate transcription.
A plasmid/virus used to express the protein in various types of host cells is an expression vector/expression construct. An expression vector is used to insert a gene into a target cell. It triggers the cell's ability to produce the protein encoded by that gene. This market is slowly growing due to the rising demand for protein-based drugs (biologics), the high prevalence of lifestyle diseases and infectious diseases, as well as increasing funding for protein therapy and research. However, the market's slow growth is impeded by high market consolidation. This increases entry barriers and the high cost of protein therapy. This market offers new growth opportunities due to the high growth potential of emerging economies. Due to the increasing demand for protein-based drugs, the global expression vectors market will experience a lucrative growth rate over the forecast period. Other factors that are likely to drive the growth of the expression vectors market include the high prevalence of genetic disorders and lifestyle-related diseases. The market will grow due to advances in protein expression and the introduction of advanced technologies within genetics, molecular biology, and bioinformatics. Market growth is expected to be boosted by the anticipated rise in unmet medical needs due to the expiration of patents on generic drugs. Expression vectors are expected to be positively impacted by the large-scale production of insulin from human cells and other protein-based products that employ expression vectors. The market is expected to grow significantly over the forecast period due to the high use of expression vectors in R D for biomedical and pharmaceutical products. However, the high cost of research using expression vectors is a major inhibitor to market growth.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Expression Vectors Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Expression Vectors Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• Sigma-Aldrich Corporation
• Thermo Fisher Scientific
• Agilent Technologies
• Promega Corporation
• Bio-rad Laboratories
• Merck Millipore
• GenScript
• New England Biolabs
• Clontech Laboratories Inc
• DNA 2.0
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Host Type
• Mammalian Expression Vectors
o CHO Expression Vectors
o Other mammalian Expression Vectors
• Bacterial Expression Vectors
o E.Coli Expression Vectors
o Other Bacterial Expression Vectors
• Insect Expression Vectors
o Baculovirus Expression Vectors
o Other Insect Expression Vectors
• Yeast Expression Vectors
o Saccharomyces Cerevisiae Expression Vectors
o K.Lactis Expression Vectors
o Pichia Pastoris Expression Vectors
o Other Yeast Expression Vectors
• Other Expression vectos
By Application
• Research Applications
• Therapuetic Applications
• Industrial Applications
By End User
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organisations (CROs) and Contract Manufacturing organisations (CMOs)
By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Expression Vectors Market By Host Type, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Expression Vectors Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Expression Vectors Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Expression Vectors Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Expression Vectors Market, By Host Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Mammalian Expression Vectors
         1.1. CHO Expression Vectors
         1.2. Other mammalian Expression Vectors
        2. Bacterial Expression Vectors
          2.1. E.Coli Expression Vectors
         2.2. Other Bacterial Expression Vectors
        3. Insect Expression Vectors
         3.1. Baculovirus Expression Vectors
         3.2. Other Insect Expression Vectors
        4. Yeast Expression Vectors
         4.1. Saccharomyces Cerevisiae Expression Vectors
          4.2. K.Lactis Expression Vectors
         4.3. Pichia Pastoris Expression Vectors
         4.4. Other Yeast Expression Vectors
        5. Other Expression vectos
  • 8.   Expression Vectors Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Research Applications
        2. Therapuetic Applications
        3. Industrial Applications
  • 9.   Expression Vectors Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Pharmaceutical and Biotechnology Companies
        2. Academic Research Institutes
        3. Contract Research Organisations (CROs) and Contract Manufacturing organisations (CMOs)
  • 10.   North America Expression Vectors Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032
  • 11.   Latin America Expression Vectors Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032
  • 12.   Europe Expression Vectors Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032
  • 13.   Asia Pacific Expression Vectors Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032
  • 14.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032
  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Sigma-Aldrich Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Thermo Fisher Scientific
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Agilent Technologies
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Promega Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bio-rad Laboratories
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bio-rad Laboratories
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Merck Millipore
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. GenScript
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. New England Biolabs
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Clontech Laboratories Inc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.DNA 2.0
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients